Intraoperative electroneurography: management of ulnar neuropathy at the elbow.
W W Campbell, S K Sahni, R M Pridgeon...
https://pubmed.ncbi.nlm.nih.gov/2828944/Actively Recruiting
Led by The Methodist Hospital Research Institute · Updated on 2026-03-30
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying how two types of spinal cord stimulation, epidural spinal stimulation ESS and transcutaneous spinal stimulation TSS, can help people with complete motor paralysis regain the ability to stand and control their lower limbs after a spinal cord injury. This study aims to understand the different physiological effects of these two stimulation methods and compare their impact on maintaining self-assisted standing in individuals with chronic spinal cord injury. The investigation focuses on improving motor function and mobility through targeted neuromodulation approaches. Participants will receive spinal stimulation either through a non-invasive method using surface electrodes placed on the skin TSS or through an implanted device delivering epidural stimulation ESS. There is also a sham stimulation group where stimulation intensity is gradually reduced to zero during sessions. The study involves randomized assignment to these groups, with stimulation delivered during research visits. The ESS device involves surgery to implant and later remove the stimulator. The study also includes activity-based training combined with stimulation to assess therapeutic effects. During the study, participants will be evaluated at multiple time points including baseline, post-intervention, and follow-up weeks. Assessments include measuring force generated by the lower limbs, neurological status, and independence in daily activities. Participants must tolerate supported standing and perform self-transfers. Safety is monitored throughout, and participants are followed for several weeks after interventions to observe sustained effects. The total study duration includes baseline assessments, intervention delivery, and follow-up evaluations.
CONDITIONS
Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury
J
Jenny Dinh, BS
A
Amanda Howes-Keith, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The Methodist Hospital Research Institute
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Epidural Spinal Stimulation (ESS) | Transcutaneous Spinal Stimulation (TSS) | Sham (Inactive Stimulation) |
|---|---|---|---|
| What is it? | Surgically implanted epidural stimulator (CoverEdgeX 32 Surgical Lead, Boston Scientific) placed on the spinal cord to deliver electrical stimulation for lower limb muscle activation in people with chronic spinal cord injury. | Non-invasive transcutaneous electrical stimulation applied through the skin over the spinal cord to promote neuromodulation for motor function recovery. | Sham stimulation procedure resembling the intervention but without delivering active therapeutic electrical stimulation. |
| Role in the clinical trial | Investigational arm designed to test whether direct epidural stimulation improves functional motor recovery in chronic spinal cord injury patients. | Active comparator arm evaluating the effectiveness of non-invasive neuromodulation compared to ESS and sham. | Control group used to separate the effects of active stimulation from placebo and routine rehabilitation. |
| Primary use or purpose | To improve voluntary force generation by the lower limbs and support standing or stepping abilities in adults with chronic SCI. | To enhance lower limb muscle activation and postural control using non-invasive spinal neuromodulation. | To act as a comparison group, allowing the effect of active interventions to be measured against inactive stimulation. |
| How it is given or performed | ESS involves a surgical procedure to implant an electrode on the spinal cord, delivering programmed stimulation sessions. The device is removed at a later visit. | TSS uses surface electrodes placed on the skin over the spinal cord. Stimulation is non-invasive and administered during study sessions. | The sham group undergoes procedures that mimic the real interventions but does not receive active therapeutic stimulation. |
| Evidence status as of trial start | Small studies have shown epidural spinal cord stimulation can enable voluntary motor functions, including stepping and standing, in some participants with chronic SCI, but efficacy varies and broader clinical adoption remains investigational. | Early clinical studies suggest non-invasive transcutaneous spinal stimulation can support motor activity and improve upright standing in selected cases of SCI, but results are variable and larger trials are needed. | No expected therapeutic benefit; sham procedures act as placebos for study blinding and measurement of non-specific effects. |
| Important limitations or uncertainties | ESS requires invasive surgery with associated procedural risks. Benefits may not generalize to all SCI populations or severities, and functional gains have been most frequently reported in small research studies. | TSS effects are highly variable by individual, with unclear optimal protocols. Improvements may be less robust than with invasive stimulation, and long-term effects are not established. | No direct benefit for motor recovery is expected; serves only as a control. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 10 weeks
Participants receive either non-invasive transcutaneous spinal cord stimulation or epidural spinal stimulation, with the latter involving surgery to implant the device.
Multiple research visits during stimulation sessions
Duration - 5 weeks after intervention
Participants are monitored after the intervention to assess neurological status, force generation, and independence.
1 follow-up visit
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
W W Campbell, S K Sahni, R M Pridgeon...
https://pubmed.ncbi.nlm.nih.gov/2828944/Dimitry G Sayenko, Mrinal Rath, Adam R Ferguson...
https://pubmed.ncbi.nlm.nih.gov/30362876/M Muñoz Pérez, M Cortés Velasco, G Martínez Elizondo...
https://pubmed.ncbi.nlm.nih.gov/3154251/Megan L Gill, Peter J Grahn, Jonathan S Calvert...
https://pubmed.ncbi.nlm.nih.gov/30250140/F Biering-Sørensen, B Hansen, B S B Lee
https://pubmed.ncbi.nlm.nih.gov/19172152/Claudia A Angeli, Maxwell Boakye, Rebekah A Morton...
https://pubmed.ncbi.nlm.nih.gov/30247091/J S Walter, P G Sola, J Sacks...
https://pubmed.ncbi.nlm.nih.gov/10685379/V Reggie Edgerton, Grégoire Courtine, Yury P Gerasimenko...
https://pubmed.ncbi.nlm.nih.gov/18022244/Susan J Harkema, Christie K Ferreira, Rubia J van den Brand...
https://pubmed.ncbi.nlm.nih.gov/19118454/G J Snoek, M J IJzerman, H J Hermens...
https://pubmed.ncbi.nlm.nih.gov/15224087/The Methodist Hospital Research Institute
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor